Those of you who attended our presentation this morning at EXL Digital Pharma West can view our slides courtesy of SlideShare:
If you weren't able to attend, here are some key takeaways:
- Quantitative measures of pharma buzz can be misleading
- Using qualitative analysis can provide a robust alternative, particularly when findings are put into the context of the patient journey
- The patient journey has far-reaching usefulness for brands: It can provide the building blocks for all phases of a consumer marketing program
- Key intervention points we found along the rheumatoid arthritis journey included Diagnosis, Transition to Engagement, Treatment Initiation, and Moving Forward Through Setbacks
- Pharma brands can use social media conversations to create their own journeys and identify key intervention points, educational needs, and marketing implications along the way
Jeff Greene
Director of Strategic Services
HealthEd
Comments